Regulation of the estrogen receptor α minimal promoter by Sp1, USF-1 and ERα

Breast Cancer Research and Treatment

Volumn 85, Issue 2, 2004, Pages 111-120

  DeGraffenried, Linda A ^a   Hopp, Torsten A ^b   Valente, Anthony J ^a   Clark, Robert A ^a   Fuqua, Suzanne A W ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Estrogen receptor; Sp1; Transcription; USF 1

Indexed keywords

ESTROGEN RECEPTOR ALPHA; TRANSCRIPTION FACTOR SP1;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE CONTROL; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

BREAST NEOPLASMS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTROGEN RECEPTOR ALPHA; FEMALE; HELIX-LOOP-HELIX MOTIFS; HUMANS; LEUCINE ZIPPERS; PLASMIDS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UPSTREAM STIMULATORY FACTORS;

EID: 3342892360     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000025398.93829.78     Document Type: Article

References (72)

1. McGuire WL, Chamness GC: Studies on the estrogen receptor in breast cancer. Adv Exp Med Biol 36: 113-136, 1973
2. McGuire WL, Carbone PP, Vollmer EP: Estrogen Receptors in Human Breast Cancer. Raven Press, New York
3. Khan SA, Rogers MA, Obando JA, Tamsen A: Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 54: 993-997, 1994
4. Khan SA, Rogers MA, Khurana KK, Meguid MM, Numann PJ: Estrogen receptor expression in benign breast epithelium and breast cancer risk [see comments]. J Natl Cancer Inst 90: 37-12, 1998
5. Fanelli MA, Vargas-Roig LM, Gago FE, Tello O, Lucero De Angelis R, Ciocca DR: Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer. Breast Cancer Res Treat 37: 217-228, 1996
6. Netto GJ, Cheek JH, Zachariah NY, Romer JC, Lee CF, Schoenfeld R, Chakmakjian ZH: Steroid receptors in benign mastectomy tissue. Am J Clin Pathol 94: 14-27, 1990
7. Allegra JC, Lippman ME, Green L, Barlock A, Simon R, Thompson EB, Huff KK, Griffin W: Estrogen receptor values in patients with benign breast disease. Cancer 44: 228-231, 1979
8. van Agthoven T, Timmermans M, Dorssers LC, Henzen-Logmans SC: Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer. Int J Cancer 63: 790-793, 1995
9. Martin MB, Saceda M, Garcia-Morales P, Gottardis MM: Regulation of estrogen receptor expression. Breast Cancer Res Treat 31: 183-189, 1994
10. Barrett-Lee PJ, Travers MT, McClelland RA, Luqmani Y, Coombes RC: Characterization of estrogen receptor messenger RNA in human breast cancer. Cancer Res 47: 6653-6659, 1987
11. Henry JA, Nicholson S, Farndon JR, Westley BR, May FE: Measurement of oestrogen receptor mRNA levels in human breast tumours. Br J Cancer 58: 600-605, 1988
12. Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson NS, Gazet JC, Nolan C, Coombes RC: Estrogen and progesterone receptors in the normal female breast. Cancer Res 51: 1817-1822, 1991
13. Weigel RJ, deConinck EC: Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res 53: 3472-3474, 1993
14. Saceda M, Lindsey RK, Solomon H, Angeloni SV, Martin MB: Estradiol regulates estrogen receptor mRNA stability. J Steroid Biochem Mol Biol 66: 113-120, 1998
15. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD, Martin, MB: The role of transforming growth factor-beta in the regulation of estrogen receptor expression in the MCF-7 breast cancer cell line. Endocrinology 138: 1498-1505, 1997
16. Read LD, Greene GL, Katzenellenbogen BS: Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol Endocrinol 3: 295-304, 1989
17. Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, Muller MT, Davidson NE: Role of estrogen receptor gene demethylation and DNA methyltransferase. DNA adduct formation in 5-aza-2′deoxycytidine-induced cytotoxicity in human breast cancer cells. J Biol Chem 272: 32260-32266, 1997
18. Ferguson AT, Lapidus RG, Baylin SB, Davidson NE: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res 55: 2279-2283, 1995
19. Chen Z, Ko A, Yang J, Jordan VC: Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells. Br J Cancer 77: 181-185, 1998
20. Piva R, Del Senno L: Analysis of a DNA sequence upstream of the human estrogen receptor gene. Ann NY Acad Sci 684: 235-238, 1993
21. Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, Scrace G, Waterfield M, Chambon P: Cloning of the human oestrogen receptor cDNA. J Steroid Biochem 24: 77-83, 1986
22. Thompson DA, McPherson LA, Carmeci C, deConinck EC, Weigel RJ: Identification of two estrogen receptor transcripts with novel 5′ exons isolated from a MCF7 cDNA library. J Steroid Biochem Mol Biol 62: 143-153, 1997
23. Grandien K: Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform. Mol Cell Endocrinol 116: 207-212, 1996
24. Grandien K, Backdahl M, Ljunggren O, Gustafsson JA, Berkenstam A: Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. Endocrinology 136: 2223-2229, 1995
25. Grandien K: Transcriptional Control of ER Expression. Department of Medical Nutrition and Novum, Stockholm, 1997, p. 57
26. Hayashi S, Imai K, Suga K, Kurihara T, Higashi Y, Nakachi K: Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis 18: 459-164, 1997
27. Hayashi S, Yoshida T: [Regulation of ER(estrogen receptor) gene expression in the genesis and development of breast cancer]. Nippon Rinsho 58: 495-503, 2000
28. Donaghue C, Westley BR, May FE: Selective promoter usage of the human estrogen receptor-alpha gene and its regulation by estrogen. Mol Endocrinol 13: 1934-1950, 1999
29. Tang Z, Treilleux I, Brown M: A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers. Mol Cell Biol 17: 1274-1280, 1997
30. deConinck EC, McPherson LA, Weigel RJ: Transcriptional regulation of estrogen receptor in breast carcinomas. Mol Cell Biol 15: 2191-2196, 1995
31. McPherson LA, Baichwal VR, Weigel RJ: Identification of ERF-1 as a member of the AP2 transcription factor family. Proc Natl Acad Sci USA 94: 4342-4347, 1997
32. deGraffenried LA, Hilsenbeck SG, Fuqua SA: Sp1 is essential for estrogen receptor alpha gene transcription. J Steroid Biochem Mol Biol 82: 7-18, 2002
33. Bigger CB, Casanova EA, Gardner PD: Transcriptional regulation of neuronal nicotinic acetylcholine receptor genes. Functional interactions between Sp1 and the rat beta4 subunit gene promoter. J Biol Chem 271: 32842-32848, 1996
34. Fischer KD, Haese A, Nowock J: Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. J Biol Chem 268: 23915-23923, 1993
35. Dang CV, Dolde C, Gillison ML, Kato GJ: Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins. Proc Natl Acad Sci USA 89: 599-602, 1992
36. Rippe RA, Umezawa A, Kimball JP, Breindl M, Brenner DA: Binding of upstream stimulatory factor to an E-box in the 3′-flanking region stimulates alpha1(I) collagen gene transcription. J Biol Chem 272: 1753-1760, 1997
37. Castles CG, Oesterreich S, Hansen R, Fuqua SA: Autoregulation of the estrogen receptor promoter. J Steroid Biochem Mol Biol 62: 155-163, 1997
38. Vyhlidal C, Samudio I, Kladde MP, Safe S: Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J Mol Endocrinol 24: 329-338, 2000
39. Wang F, Duan R, Chirgwin J, Safe SH: Transcriptional activation of cathepsin D gene expression by growth factors. J Mol Endocrinol 24: 193-202, 2000
40. Salvatori L, Ravenna L, Felli MP, Cardillo MR, Russo MA, Frati L, Gulino A, Petrangeli E: Identification of an estrogen-mediated deoxyribonucleic acid-binding independent transactivation pathway on the epidermal growth factor receptor gene promoter. Endocrinology 141: 2266-2274, 2000
41. Duan R, Porter W, Safe S: Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology 139: 1981-1990, 1998
42. Xing W, Archer TK: Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. Mol Endocrinol 12: 1310-1321, 1998
43. Treilleux, Peloux N, Brown M, Sergeant A: Human estrogen receptor (ER) gene promoter-P1: estradiol-independent activity and estradiol inducibility in ER+ and ER- cells. Mol Endocrinol 11: 1319-1331, 1997
44. Hori M, Iwasaki M, Shimazaki J, Inagawa S, Itabashi M: Assessment of hypermethylated DNA in two promoter regions of the estrogen receptor alpha gene in human endometrial diseases. Gynecol Oncol 76: 89-96, 2000
45. Weigel RJ, Crooks DL, Iglehart JD, deConinck EC: Quantitative analysis of the transcriptional start sites of estrogen receptor in breast carcinoma. Cell Growth Differ 6: 707-711, 1995
46. Grandien K, Berkenstam A, Gustafsson JA: The estrogen receptor gene: promoter organization and expression. Int J Biochem Cell Biol 29: 1343-1369, 1997
47. Flouriot G, Griffin C, Kenealy M, Sonntag-Buck V, Gannon F: Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage. Mol Endocrinol 12: 1939-1954, 1998
48. Kadonaga JT, Courey AJ, Ladika J, Tjian R: Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 242: 1566-1570, 1988
49. Jackson SP, MacDonald JJ, Lees-Miller S, Tjian R: GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63: 155-165, 1990
50. Dynan WS, Sazer S, Tjian R, Schimke RT: Transcription factor Sp1 recognizes a DNA sequence in the mouse dihydrofolate reductase promoter. Nature 319: 246-248, 1986
51. Wright KL, Moore TL, Vilen BJ, Brown AM, Ting JP: Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J Biol Chem 270: 20978-20986, 1995
52. Rohr O, Aunis D, Schaeffer E: COUP-TF and Sp1 interact and cooperate in the transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat in human microglial cells. J Biol Chem 272: 31149-31155, 1997
53. Schanke JT, Durning M, Johnson KJ, Bennett LK, Golos TG: SP1/SP3-binding sites and adjacent elements contribute to basal and cyclic adenosine 3′,5′-monophosphate-stimulated transcriptional activation of the rhesus growth hormone-variant gene in trophoblasts [In Process Citation]. Mol Endocrinol 12: 405-417, 1998
54. Carrasco-Serrano C, Campos-Caro A, Viniegra S, Ballesta JJ, Criado M: GC- and E-box motifs as regulatory elements in the proximal promoter region of the neuronal nicotinic receptor alpha7 subunit gene. J Biol Chem 273: 20021-20028, 1998
55. Pagliuca A, Cannada-Bartoli P, Lania L: A role for Sp and helix-loop-helix transcription factors in the regulation of the human Id4 gene promoter activity. J Biol Chem 273: 7668-7674, 1998
56. Ulgiati D, Subrata LS, Abraham LJ: The role of Sp family members, basic Kruppel-like factor, and E box factors in the basal and IFN-gamma regulated expression of the human complement C4 promoter. J Immunol 164: 300-307, 2000
57. Liu HC, Shen JT, Augustin LB, Ko JL, Loh HH: Transcriptional regulation of mouse delta-opioid receptor gene. J Biol Chem 274: 23617-23626, 1999
58. Gobin SJ, van Zutphen M, Woltman AM, van den Elsen PJ: Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J Immunol 163: 1428-1434, 1999
59. Li Q, Hu N, Daggett MA, Chu WA, Bittel D, Johnson JA, Andrews GK: Participation of upstream stimulator factor (USF) in cadmium-induction of the mouse metallothionein-I gene. Nucl Acids Res 26: 5182-5189, 1998
60. Takahashi Y, Nakayama K, Itoh S, Kamataki T: Upstream stimulatory factor 1 (USF1) suppresses induction of CYP1A1 mRNA by 3-methylcholanthrene (MC) in HepG2 cells. Biochem Biophys Res Commun 240: 293-297, 1997
61. Ferre-D'Amare AR, Pognonec P, Roeder RG, Burley SK: Structure and function of the b/HLH/Z domain of USF. Embo J 13: 180-189, 1994
62. Lefrancois-Martinez AM, Martinez A, Antoine B, Raymondjean M, Kahn A: Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem 270: 2640-2643, 1995
63. Scholz A, Truss M, Beato M: Hormone-induced recruitment of Sp1 mediates estrogen activation of the rabbit uteroglobin gene in endometrial epithelium. J Biol Chem 273: 4360-4366, 1998
64. Krishnan V, Wang X, Safe S: Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269: 15912-15917, 1994
65. Porter W, Saville B, Hoivik D, Safe S: Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11: 1569-1580, 1997
66. Roy AL, Du H, Gregor PD, Novina CD, Martinez E, Roeder RG: Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. Embo J 16: 7091-7104, 1997
67. Oesterreich S, Zhang Q, Hopp T, Fuqua SA, Michaelis M, Zhao HH, Davie JR, Osborne CK, Lee AV: Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. Mol Endocrinol 14: 369-381, 2000
68. Fuqua SA, Benedix MG, Krieg S, Weng CN, Chamness GC, Oesterreich S: Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells. Breast Cancer Res Treat 32: 177-186, 1994
69. Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL: HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7: 1120-1128, 1989
70. Dynan WS, Tjian R: The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35: 79-87, 1983
71. Hough PV, Mastrangelo IA, Wall JS, Hainfeld JF, Sawadogo M, Roeder RG: The gene-specific initiation factor USF (upstream stimulatory factor) bound at the adenovirus type 2 major late promoter: mass and three-dimensional structure. Proc Natl Acad Sci USA 84: 4826-4830, 1987
72. Kreider BL, Benezra R, Rovera G, Kadesch T: Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science 255: 1700-1702, 1992